DrugDashboards

Dopamine Hydrochloride and Dextrose

Dopamine Hydrochloride · DOPAMINE HYDROCHLORIDE 80 mg/100mL · Injection, Solution · Intravenous · Baxter Healthcare Corporation

NDC 00338-1005-02 · 18 BAG in 1 CARTON / 250 mL in 1 BAG · NDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now. One of its named manufacturing plants, Baxter Healthcare Corporation, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$1.01per billing unit (40 MG)HCPCS J1265 · Jul 1, 2026
  • Federal contracts pay (FSS)$129.96per package of 18X250MLBaxter Healthcare Corporation · Sep 17, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$11.65
Reported to Texas DSHS · 2026 annual filing · Baxter Healthcare Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 40 MG
$1.012
HCPCS J1265 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA019615
TE code
AP
Approval date
Mar 27, 1987
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

  • Class II · TerminatedSep 29, 2014
    Baxter Healthcare Corp. — Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.

Manufacturers of Dopamine Hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDOPAMINE HYDROCHLORIDE 160 mg/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDOPAMINE HYDROCHLORIDE 320 mg/100mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDOPAMINE HYDROCHLORIDE 80 mg/100mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDOPAMINE HYDROCHLORIDE 1.6 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDOPAMINE HYDROCHLORIDE 160 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dopamine Hydrochloride and Dextrose — NDC 00338-1005-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00338100502.

Free to cite with attribution — see how the data is put together.